Both in Biotechnology
Gilead Sciences vs Halozyme Therapeutics
Over the past year GILD returned +42.5% and HALO returned +100.8%; their daily moves had a correlation of 0.36.
GILD +42.5% HALO +100.8%Growth of $1, one year, split-adjusted
| Metric | GILD | HALO |
|---|---|---|
| Price | $170.68 | $130.91 |
| Market cap | $211.70B | $14.86B |
| Today | +3.06% | −0.21% |
| 1 month | +15.7% | +22.4% |
| 6 months | +29.6% | +104.7% |
| Year to date | +39.1% | +94.5% |
| 1 year | +44.0% | +100.6% |
| Revenue growth (YoY) | +6.8% | +47.7% |
| Gross margin | 81.1% | 83.5% |
| Net margin | 29.3% | 47.8% |
| P/E (TTM) | — | 35.9× |
| Price / sales | 6.8× | 8.9× |
| Net cash | -$19.79B | -$1.92B |
| Dividend yield | 1.92% | — |
| Volatility (60d) | 25.5% | 45.9% |
| Short % of float | 1.6% | 12.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).